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ABSTRACT
Although increasingly used for DNA quanti®cation,
little is known of the dynamics of the 5¢ exonuclease
assay, particularly in relation to amplicon length
and mismatches at oligonucleotide binding sites. In
this study we used seven assays targeting the
c-myc proto-oncogene to examine the effects of
sequence length, and report a marked reduction in
ef®ciency with increasing fragment length. Three of
the assays were further tested on 15 mammalian
species to gauge the effect of sequence differences
on performance. We show that the effects of probe
and primer binding site mismatches are complex,
with single point mutations often having little effect
on assay performance, while multiple mismatches
to the probe caused the greatest reduction in ef®-
ciency. The usefulness of the assays in predicting
rates of `allelic dropout' and successful polymerase
chain reactions (PCRs) in microsatellite genotyping
studies is supported, and we demonstrate that the
use of a fragment more similar in size to typical
microsatellites (190 bp) is no more informative than
a shorter (81 bp) fragment. The assays designed for
this study can be used directly for quanti®cation of
DNA from many mammalian species or, alternat-
ively, information provided here can be used to
design unique sequence-speci®c assays to maximise
assay ef®ciency.
INTRODUCTION
In recent years, the 5¢ exonuclease assay (1,2) has become the
method of choice for accurate quanti®cation of DNA extracts
(3±8). Other methods, such as ¯uorometric analysis and
competitive polymerase chain reaction (PCR), are hampered
by the lack of speci®city for host DNA and the limited linear
range for quanti®cation (8,9). The 5¢ exonuclease assay
incorporates the use of a double-labelled, template-speci®c
probe that binds to the target DNA before being cleaved by the
5¢±3¢ exonuclease activity of the Taq polymerase. This
cleavage of the probe results in the release of signal from
the `reporter' ¯uorescent dye. The intensity of the reporter
¯uorescence throughout the PCR cycle corresponds directly to
the number of copies of PCR product present at each stage of
the cycle. Samples of unknown concentration are compared
with a standard curve created from samples of known DNA
concentration, to estimate starting DNA template amount with
a dynamic range of at least ®ve orders of magnitude (7).
Quantitative PCR (qPCR) has also been used as a method
for analysing low concentration DNA extracts such as those
derived from non-invasive samples collected for use in
wildlife genetic studies (8). Accurate quanti®cation of such
samples allows for a streamlined approach to the number of
repetitions required for 99% con®dence in genotypes obtained
(8,10). However, possible problems that could compromise
this application include (i) reduced ef®ciency of the assay for
samples with minor mismatches at the probe binding site that,
if undetected, will give inaccurate estimates of DNA quantity;
(ii) quanti®cation of contaminating human (or other) DNA
instead of (or in addition to) target DNA; and (iii) possible
discordance between results obtained for the short qPCR assay
amplicon to the relatively larger amplicons typically used for
microsatellite genotyping. This latter point is confounded by
observations of a decrease in assay ef®ciency with an increase
in assay amplicon length (11).
Klein et al. (6) have investigated the effects of probe
mismatches on the ef®ciency of the 5¢ nuclease assay, but the
number of mismatches investigated was low, and there has
been no attempt to characterise how such mismatches interact
with other factors such as amplicon length and species-related
DNA sequence differences to affect assay performance. Such
information is useful for assessing the applicability of a given
qPCR assay across a range of species or highly variable DNA
sequences.
We designed seven separate 5¢ exonuclease assays ranging
from 81 to 429 bp in length. The aim of this study was to use
these assays in association with a panel of 15 mammalian
DNA samples to assess the performance of the assay on DNA
fragments of different length within and across species. For
each of the species, we sequenced the assay target region to
provide exact data on number and placement of primer and
probe mismatches. This information then made it possible to
investigate a number of interactions between target template
and assay performance. Previous work has concentrated
on determining assay ef®ciency by examining the slope
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characteristics of the assay standard curve (6,12). In this study
we utilise this method, but also introduce a system whereby
the slope characteristics of the actual sample ampli®cation
plots are used, allowing direct assessment of assay ef®ciency
between individual samples.
Finally, we tested whether the use of a qPCR assay that
measures the quantity of DNA template for an amplicon size
more typical of microsatellite loci would be a better predictor
of PCR success and allelic dropout (AD) frequencies in studies
using low quantity or quality DNA samples. AD is the
stochastic ampli®cation of only one of two alleles at a
heterozygote locus that, if undetected, leads to the false
inference of a homozygous genotype at that locus (8,13,14).
We compared the results of two differently sized qPCR assays
with previous data on percentage positive PCR and AD rates
for samples from a population of wild chimpanzees (8) to




A panel of 15 genomic DNA samples was constructed from
commercial and private sources to test the phylogenetic
coverage of the assays (Table 1). These high quality DNAs
were extracted from cell line or blood samples by the suppliers
(Table 1). Their concentrations were estimated ®rst by
absorbance at 260 nm (A260) in a spectrophotometer and
then diluted with 0.13 TE buffer (10 mM Tris, 0.1 mM
EDTA, pH 8.0) into aliquots with an approximate starting
concentration of 10 ng/ml. Aliquots were stored frozen at
±20°C.
Assay design and implementation
Seven 5¢ exonuclease qPCR assays of different lengths were
designed from an alignment of the c-myc proto-oncogene
DNA sequences from mouse (GenBank accession no.
X01023) and human (accession no. J00120). The smallest
assay, c-myc81, is 81 bp in length and has been described
previously (8). The design of the other assays, c-myc105,
c-myc113, c-myc190, c-myc239, c-myc320 and c-myc429,
followed published guidelines (11,15). Primers and probes for
these assays were designed using the software Primer
ExpressÔ (V. 1.0; Applied Biosystems, Foster City, CA)
and their sequences are given in Table 2. Primer and probe
combinations for each assay are given in Table 3 and their
position on the target sequence is shown in Figure 1. Reaction
conditions were the same for all assays and were carried out in
PCR volumes of 20 ml containing 2 ml of 103 Taqman
Reaction System buffer (Eurogentec, Belgium), 4.5 mM
MgCl2, 250 mM each of dATP, dCTP, dGTP, dTTP and dUTP,
Table 1. DNA type and source
Species Source c-myc sequence
accession
Sus scrofa (pig) Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Braunschweig, Germany.
ID AM-C6SC8
AF519454
Bos taurus (cow) DSMZ. ID EBL AF519455
Ovis aries (sheep) Coriell Cell Repositories (CCR), Camden, New Jersey. ID GM03550 Z68501
Felis cattus (domestic cat) CCR ID GM06206 AF519449
Mus musculus (mouse) CCR ID GM00346B AF519452
Cricetulus griseus (Chinese hamster) CCR ID GM00215A AF519453
Oryctolagus cuniculusi (rabbit) CCR ID AG04677A AF519451
Cuon alpinus (dhole) Dr Arati Iyengar, Laboratory for Conservation Genetics, Max Planck Institute for Evolutionary
Anthropology, Leipzig, Germany
AF519448
Pan troglodytes verus (chimpanzee) Jo Fritz, Primate Foundation of Arizona, Phoenix, AZ AF519445
Saguinus oedipus (marmoset) DSMZ ID B95-8 AF519447
Papio hamadryas (baboon) Dr Jeff Rogers, Southwest Foundation for Biomedical Research, San Antonio, TX AF519446
Loxodonta africana (elephant) Dr William J. Murphy Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD AF519456
Asioscalops altaica (mole) Dr William J. Murphy AF519458
Chaetophractus villosus (armadillo) Dr William J. Murphy AF519457
Plecotus auritus (micro bat) Dr Tamsyn Burland, School of Biological Sciences, Queen Mary, University of London AF519450
Didelphis virgianus (opossum) Dr William J. Murphy Not applicable
Table 2. Primer and probe sequences
Oligo 5¢ End Middle 3¢ End
CMYC_E3_F1 GCCAGA GGAGGAA CGAGCT
CMYC_E3_F2 GGCGAAC ACACAAC GTCTTGG
CMYC_E3_F4 AGGCCA CAGCAA ACCTCC
CMYC_E3_R1 GGGCCTT TTCATTG TTTTCCA
CMYC_E3_R5 TGGCAGC AGGATA GTCCTTC
CMYC_E3_R6 TTTCAACT GTTCTCG TCGTTTCC
CMYC_E3_R7 GGCGCT CCAAG ACGTTG
CMYC_TMV1 TGCCCTG CGTGAC CAGATCC
CMYC_TMV2 CACAGCCC ACTGGTCC TCAAGAGG
CMYC_seq_F1 GAAATCG ATGTTGT TTCTGTG
CMYC_seq_R1 CAAGAGT TCCGTA GCTGTTC
Probes (TMV1 and TMV2) were labelled with VIC on the 5¢ end and with
TAMRA on the 3¢ end.
Table 3. Assay primer and probe combinations
Assay Forward primer Probe Reverse primer
c-myc81 CMYC_E3_F1 CMYC_TMV1 CMYC_E3_R1
c-myc105 CMYC_E3_F2 CMYC_TMV1 CMYC_E3_R1
c-myc113 CMYC_E3_F4 CMYC_TMV2 CMYC_E3_R5
c-myc190 CMYC_E3_F1 CMYC_TMV1 CMYC_E3_R6
c-myc239 CMYC_E3_F4 CMYC_TMV2 CMYC_E3_R7
c-myc320 CMYC_E3_F4 CMYC_TMV2 CMYC_E3_R1
c-myc429 CMYC_E3_F4 CMYC_TMV2 CMYC_E3_R6
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0.5 U HotGoldStar Taq polymerase (Eurogentec), 0.8 mg/ml
BSA, 0.01 U/ml uracil-DNA-glycosylase (Roche, Germany),
300 nM of each primer, 200 nM probe and 5 ml DNA template.
Cycling was performed on an ABI PrismÔ 7700 Sequence
Detector (Applied Biosystems) with conditions as described in
Morin et al. (8).
As an initial assessment of their performance, all seven
assays were tested on a triplicate set of standards prepared and
HPLC-quanti®ed by Roboscreen (Leipzig, Germany) (16).
The standard set comprised a 2-fold dilution series of a PCR
product ampli®ed from a 429 bp portion of the c-myc proto-
oncogene and ranged from 5050 to 39 copies. The ef®ciency
of the standard curves and ampli®cation plots was analysed
(see Fig. 3) and three assays (c-myc81, c-myc190 and
c-myc239) were selected based on fragment size and assay
performance for further use with the mammalian samples. All
three assays failed for the opossum DNA so it was decided to
exclude it from further analysis as marsupials represent a
highly divergent lineage at this gene.
Prior to the sample assays, a triplicate set of standards (from
1010 to 8 copies) was run to create the reference standard
curve for ampli®able DNA calculation. Because this standard
was a PCR product it was important that it be prepared and run
separately from the sample plate to avoid possible carry-over
contamination. Six `no template controls' were included on
the standard plate to monitor for master-mix reagent con-
tamination. A single reagent cocktail was used for the
standards, negative controls and test DNA samples. Data
analysis was performed using the ABI PrismÔ 7700 Sequence
Detector software, and standard curves and quantities were
calculated according to Morin et al. (8). For each assay,
averages of three replicates were used for the standard curve,
and all data points were used for each assay except c-myc239,
for which the last data point, corresponding to eight copies,
was deleted because of failed or aberrant reactions.
Sequencing of the target region
The published sequences of exons 2 and 3 of the c-myc proto-
oncogene for 18 eutherian mammalian species and two avian
species (17) were used to design a conserved PCR primer set
that would amplify the region of the gene containing all of the
assays (Table 2). PCR ampli®cations were performed in 15 ml
reaction volumes containing 13 reaction buffer (10 mM
Tris±HCl, 50 mM KCl, pH 8.3), 2.5 mM MgCl2, 250 mM
dNTPs, 0.3 U Taq polymerase (Roche) and 200 nM of each
primer. A `touch-down' PCR programme was employed that
consisted of a 3 min incubation at 95°C followed by step-down
cycles of 94°C for 30 s, 64°C for 30 s and 72°C for 1 min. The
annealing temperature was reduced by 1°C each cycle until an
annealing temperature of 48°C was reached. A further 13
cycles at this annealing temperature took place with a ®nal
extension phase of 72°C for 10 min. Ampli®cation products
were puri®ed using the QIAquick PCR Puri®cation Kit from
Qiagen and then sequenced using the ABI big-dye terminator
cycle sequencing kit 2.0, and electrophoresed on an ABI 3700
automated sequencer (Applied Biosystems).
The newly generated sequences were aligned with those
published by Miyamoto et al. (17) using the program Bioedit
(V. 5.0.6) (18) (aligned sequences can be viewed in the
Supplementary Material). Phylogenetic analyses of the
aligned sequences were performed using the Phylip software
package (V. 3.6) (19). A DNA distance matrix was calculated
using the F84 model (20,21) and this matrix was used to
construct a neighbour-joining tree using two avian species as
outgroups. Bootstrap support for this tree was generated by
performing 1000 re-sampling iterations of the original data set
prior to the distance matrix and tree calculations and then
creating a majority rule consensus tree (22).
Assay ef®ciency and oligonucleotide mismatch analysis
The slopes of the standard curves were used to calculate
ef®ciencies (E) of the assays using the equation E = 10±1/s ± 1,
where s = slope of the regression curve (6). The slopes of the
exponential phase of the ampli®cation plots [ampli®cation
plot slope (APS)] were determined by creating a plot of
average ¯uorescence versus cycle number using seven data
points encompassing the threshold ¯uorescence value from the
exponential phase of the original ampli®cation plot. The slope
was recorded from the equation for the linear regression
trendline of this plot and was accepted for the selected seven
data points when the R2 value exceeded 0.99. For mismatch
analysis, the probes and primers in each assay were divided
into three even parts each (when possible), as shown in
Table 2, and mismatches between the oligonucleotide and the
corresponding DNA sequence for each species were counted.
To get an indication of the effect of mismatches in each
section of each oligonucleotide, the APSs for each species
were plotted against the respective number of mismatches for
each probe section, and a linear regression was used to infer
the correlation between mismatches and assay ef®ciency (data
not shown).
Correlation with allelic dropout
A subset of the chimpanzee faecal DNA extracts used by
Morin et al. (8) were used to test the relative ability of the
assays to predict ampli®cation success and AD rates. Samples
from 45 individuals were quanti®ed using two 5¢ exonuclease
assays (c-myc81 and c-myc190). The results from these assays
were compared with the microsatellite data and information
on AD from the previous study. For ®tting regression curves,
Figure 1. Position of primer and probe oligos for the various c-myc assays
(refer to Table 3 for combinations) and c-myc target sequence. The target
fragment is a 533 bp portion of exon 3 of the c-myc proto-oncogene
(accession no. J00120).
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all data were transformed to make them non-zero (by addition
of 0.1 to the copy number and 0.1% to the percentage positive
PCR or percentage AD), and the program SPSS (version 8.0;
SPSS inc., Chicago, IL) was used to ®nd the curve that best ®t
the data by testing regressions and signi®cance levels. Tested
regression models included observed, linear, log, quadratic,
cubic, compound, power and growth.
RESULTS
Sequences and phylogeny
DNA sequences for a 533 bp fragment of the c-myc proto-
oncogene were obtained for 14 mammals. Repeated sequenc-
ing reaction failures for the opossum DNA forced its exclusion
from further analysis. The sheep DNA produced unclean
sequence so the published sequence was used for phylogenetic
and mismatch analyses. The sequences were aligned with the
previously published mammalian and bird sequences (17) and
phylogenetic analysis was done on the resulting 495 bp of
aligned sequence for 33 species (Fig. 2). The phylogenetic
relationships derived from the c-myc sequence are consistent
with relationships inferred from other molecular sequences
(23), and this locus appears to be useful for a wide range of
divergence times, from the deep branches of mammalian
radiation to closely related genera.
DNA quanti®cation: consistency of measurements
between assays
The standard curves for all assays are shown in Figure 3. The
assays exhibited different ef®ciencies, ranging from 1.08 to
0.82 (Fig. 3), which means that the number of copies of PCR
product that was produced in each cycle of the PCR was lower
in each successive assay as the length of the product increased
from 81 to 429 bp. The y-intercepts of the assays were also
signi®cantly different, with assays shifted up the y-axis as the
assay product length increased. This also re¯ects an overall
decrease in sensitivity of the longer assays, such that the
threshold ¯uorescence values are reached later in the PCR
cycling. Reduction in ef®ciency with increased length is a
typical characteristic of the 5¢ exonuclease assay (11), though
its predictability is not complete and it has not been
characterised previously in any detail.
Four of the assays exhibited E values higher than the
theoretical maximum of 1 (c-myc81, c-myc105, c-myc113
and c-myc190). The reason for this is that the estimation of
overall assay ef®ciency is affected by variations in tube-to-
tube ampli®cation ef®ciency. The E values are calculated from
the slope of the standard curve for each assay, consequently
any factors that impact on the ampli®cation ef®ciency of the
points used to construct the curve will also impact on the
calculated E value. The quanti®cation of low copy number
samples results in larger associated con®dence intervals due to
the relative impact of stochastic factors involved in the PCR
(12). When the two lowest copy number points are removed
from each of these four assays, and the calculated E values
from the individual replicates are averaged, there is no
signi®cant departure from the theoretical maximum of 1 (a =
0.05). The APS provides a more sensitive measure of
ef®ciency as it is calculated individually for each sample
undergoing PCR. The average APS values of the six replicates
for the two lowest copy number standards are signi®cantly
lower than those for the other standard points in three of the
four assays that show overall E values higher than 1 (a =
0.05). These variations within the standard assays do not affect
the relative quanti®cations within assays, as the same stand-
ards are used across all samples.
If the c-myc 5¢ exonuclease assays ef®ciently produce
¯uorescent signal that is directly proportional to the accumu-
lation of PCR product, and the ef®ciency is equal to that of the
assays performed on the standard curve sample (a PCR
product with perfect sequence match to the primers and
probes), then the estimates of DNA quantity should be
approximately the same for each assay. If an assay has reduced
ef®ciency, because of primer sequence mismatches that
reduce the rate of production of PCR product or probe
Figure 2. Unrooted phylogenetic tree constructed using the neighbour-
joining method based on genetic distance analysis of the c-myc sequences.
Genetic distances were calculated using the F84 model in the Phylip soft-
ware package (19). Bootstrap values exceeding 50% are shown on the
corresponding branches. *Indicates newly generated sequences.
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mismatches that reduce the correlation between ¯uorescent
signal and PCR product yield, the calculated amount of
starting template will be lower than the actual starting amount.
Fifteen mammalian DNA samples were quanti®ed using the
three c-myc assays (opossum failed for all three assays). For
all of the species, the 239 bp assay performed poorly or there
was no signal at all. For the two shorter assays, seven of the 15
species' DNA had higher calculated starting template amounts
with the 190 bp assay compared with the 81 bp assay, and
eight had lower amounts. This indicates an overall slightly
lower ef®ciency of the c-myc190 assay, but the ef®ciency is
somewhat sequence dependent, and the overall correlation
between the two mean starting template calculations is strong
(linear regression R2 = 0.68 for 15 species; R2 = 0.80 if the cat
sample, which had an ~3-fold difference between replicate
measures, was excluded).
Effects of sequence mismatches
The ampli®cation plots and primer and probe mismatches with
the template sequences were examined to determine whether
the differences in the calculated template amounts between
assays were due to changes in the ef®ciency of the assays, and
what factors might be involved. The slope of the exponential
phase of the ampli®cation plot (APS) was used to determine
the ef®ciency of the assay. When an assay is 100% ef®cient,
the PCR exactly doubles the number of product copies in each
cycle, and the increase in ¯uorescence will be directly
proportional to the amount of product. This will result in a
standard curve slope of ±3.333, which corresponds to a 3.333
cycle difference between dilutions in a 10-fold template DNA
dilution series (6). The slope of the exponential phase of the
ampli®cation plot is also maximised at 100% ef®ciency.
Figure 4 highlights the relationship between ef®ciency (E) as
measured by the slope of the assay standard curve and
ef®ciency as measured by the average of the slopes of the
exponential phases (APS) of the individual standard ampli®-
cation plots. It shows that there is a linear correlation until a
threshold level corresponding to a fragment length of ~190 bp
where E values plateau and the APS becomes more informa-
tive. The APS values for the three assays used on the
mammalian samples were 0.456, 0.166 and 0.172 (c-myc81,
c-myc190 and c-myc239 respectively) for the standard DNA
Figure 3. Standard curves for c-myc assays 81, 105, 113, 190, 239, 320 and 429 based on the average of three replicates (6 standard deviation). The
c-myc113 and c-myc320 assays both had single data points removed, which represented failed or aberrant reactions, and the c-myc429 assay had two points
requiring removal. The ef®ciency (E) for each assay is shown above the standard curve equation information.
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(average of three replicates for each assay, at highest
concentration of starting template). For all remaining analy-
ses, we use the APS values as surrogate measures for the
actual assay ef®ciency calculations.
We compared the observed APS values for the assays with
DNA templates of different species, and correlated changes in
primer and probe binding site sequences that might cause
signi®cant changes in assay ef®ciency. The c-myc81 assay
exhibited a non-continuous distribution of APS values for the
15 species. Samples were categorised as having APS values
>0.25 (category 3), between 0.15 and 0.25 (category 2) and
<0.15 (category 1) (Table 4). Observation of mismatches
between probe and primer binding sites showed that, for this
assay, there was a strong effect of total number of mismatches
in all primer and probe sites (R2 = 0.5663) (Fig. 5A), but the
number of mismatches in the probe binding site explained the
majority of the change in APS (R2 = 0.83) (Fig. 5B), with all
samples in category 3 having zero or one mismatch, and all
those in categories 1 and 2 having two mismatches. However,
three of the four samples with the lowest slopes also had
reverse primer mismatches in the 3¢ one-third of the reverse
primer (all 5 bp from the 3¢ terminus), so combined effects
may be causing the low observed slopes. As noted by Klein
et al. (6), simple mismatches of 1 nt in the probe or primer
binding sites do not necessarily cause signi®cant decreases in
assay ef®ciency.
The c-myc190 assay exhibited a consistently lower (all
<0.2) and more continuous variation in the APS values, as well
as a larger range of primer and probe binding site mismatches.
The APS values between assays for each species were highly
correlated [R2 = 0.4772 for 14 species; R2 = 0.9162 when cow
is removed (see below)]. Surprisingly, three species (chim-
panzee, baboon and mouse) with perfect matches between the
template and assay oligonucleotides exhibited intermediate
APS values, falling below other species that possessed up to a
total of seven mismatches, including two in the probe binding
site and four in the 3¢ one-third of the reverse primer (cow). All
probe and primer binding sites were analysed for position of
mismatches in 5¢, central or 3¢ thirds, and there was also no
clear pattern of effect. This analysis was limited by the actual
distribution of mismatches, which tended to fall in the central
portion of the forward primer, the 5¢ and central portions of the
probe and the 3¢ portion of the reverse primer binding site. The
highest correlation coef®cient between APS and number of
mismatches was for the total number of mismatches in the
probe binding site (R2 = 0.5681), followed by the number of
mismatches at the 5¢ end of the probe (R2 = 0.3439). No other
correlation coef®cients were greater than 0.2.
The c-myc239 assay exhibited slopes below 0.12 for all
species, and half of the species samples produced no assay
signal. Sequence analysis showed that only the primate and
mouse sequences had no mismatches with the probe. All other
species had between one and ®ve probe mismatches, and up to
nine total mismatches. Of those that produced a ¯uorescent
signal, there was again no clear pattern of APS versus
mismatch, though the highest correlation coef®cients were for
5¢ probe mismatch, total probe mismatch and total site
mismatch (R2 = 0.3711, 0.3568 and 0.3640 respectively). The
cow sample again was somewhat anomalous, as the APS was
higher than that of the mouse sample (three mismatches), but
there were ®ve probe site mismatches, and three more primer
binding site mismatches, for a total of eight mismatches in the
assay oligonucleotide binding sites.
Allelic dropout
Chimpanzee DNA samples, extracted from faeces collected in
the TaõÈ National Park, CoÃte d'Ivoire, were selected from a
previous study of AD and ampli®cation success (8). Thirty-
one samples, for which repeated genotyping had been
completed, were re-analysed for DNA quantity using the
c-myc81 assay after 1.5±2 years of storage at ±20°C, and also
assayed using the c-myc190 assay. Although the previous
measures were determined against a genomic DNA standard,
measured in picograms instead of copy number (so absolute
quantities were not directly comparable), samples were of the
same general concentration as measured previously, with a
correlation coef®cient between measurements of R2 = 0.7207
(n = 31).
Chimpanzee faecal samples yield very low quantities of
highly degraded DNA (8,10,13,14,24±26). It is expected, both
because of the lower ef®ciency of the assay and because of the
larger PCR product, that the c-myc190 assay would detect
smaller quantities of DNA, and that the variation in degrad-
ation between samples would introduce variation in detectable
amounts of template DNA as well. Twenty-four of the 45
faecal extracts measured by both methods yielded no detect-
able product in the c-myc190 assay (data not shown). All of
these contained small amounts (fewer than 200 copies;
average = 40 copies) of template DNA, as detected by the
c-myc81 assay, with one extract yielding no product from
either assay. For all 44 samples with detectable DNA in the
c-myc81 assay, the amount of DNA detected by the c-myc190
assay was highly positively correlated (R2 = 0.8011).
We tested multiple models to ®nd the best-®t regression
model for the relationship between ampli®able copy number
in each assay and the percentage positive PCR or percentage
AD determined from repeated genotyping of microsatellite
loci on these samples (8). Correlation coef®cients and
statistical signi®cance from SPSS statistical analysis software
indicated that the highest correlation coef®cients for signi®-
cant ®ts (P <0.006) for positive PCR were logarithmic curves
for both the c-myc81 and c-myc190 assays. For AD, the
logarithmic curve ®t best for the c-myc81 assay, but the power
Figure 4. Plot of assay ef®ciency (E), as measured by standard curve slope,
against average slope of the exponential phase of the ampli®cation plots
(APS) for each standard.
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curve ®t best for the c-myc190 assay, though the power curve
was a highly signi®cant ®t for both assays (P <0.0001).
Figure 6 shows the plots of copy number versus percentage
positive PCR and percentage AD for both assays, with the
power curve ®tted to the AD data of both assays for
comparative purposes. The correlation of both AD and
percentage positive PCR to copy number was better for the
c-myc81 assay (R2 = 0.696 and 0.591 respectively, for
c-myc81; R2 = 0.393 and 0.229 respectively, for c-myc190),
and it is clear that the c-myc190 assay rarely detects template
DNA below the level where AD rises above 5% or positive
PCR falls below 95%, so the assay is not useful for de®ning
categories of replication to ensure 99% con®dence levels for
genotypes (8,14). The 190 bp assay did not, contrary to
expectations, predict AD or positive PCR better for samples
that had relatively high levels of degradation, as indicated by
relatively low amounts of the larger assay product. There is
not suf®cient power to detect the signi®cance of the correl-
ations, but AD was detected for three samples out of the 10
with the highest amount of DNA as measured by the c-myc81
assay, but for four samples out of the highest 10 measurements
for the c-myc190 assay.
Table 4. Primer and probe mismatch scores and slope values for mammalian species
Blank cells represent missing data. NS, no signal.
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Previous studies have demonstrated that the 5¢ nuclease assay
is an accurate and reliable method for the estimation of
ampli®able DNA concentration (3,6,8), and the ®ndings of this
study support that conclusion. However, we have shown that
assay ef®ciency decreases as fragment size increases, and the
effect of various primer and probe mismatches is complicated,
but clear factors include (i) single point mutations in probe or
primer binding sites alone do not necessarily have a signi®cant
impact on assay ef®ciency; (ii) combined effects of probe and
primer mismatches possibly giving rise to more pronounced
reductions in assay ef®ciency; (iii) a strong effect of reduced
assay ef®ciency with increasing number of total primer and
probe mismatches; and (iv) mismatches at the probe binding
site having the greatest effect on assay ef®ciency.
This represents a signi®cant expansion on the data
presented by Klein et al. (6) and provides further insight
into the dynamics of the 5¢ nuclease assay. However,
correlations between ef®ciency and number or placement of
mismatches remain unclear. In some cases, perfectly matched
samples exhibit lower ef®ciency than mismatched samples,
indicating that other factors, such as secondary structure, may
affect assay ef®ciency on a particular sequence or species.
Further experimentation is required to clarify this issue. It may
be that partial complementarity to other regions of the
genomic DNA template results in probe competition in
some species. This possibility is supported by the occurrence
of pseudogenes within the myc gene family; however, there is
no evidence of this for the c-myc gene speci®cally (27).
GenBank Blast search results for the c-myc81 and c-myc190
probe do not show matches outside the c-myc gene (data not
shown) but genomic coverage of most of the mammals used in
this study is limited in the public databases.
Within an assay it is possible to detect reductions in
ef®ciency for different samples by measuring the slope of a
dilution series plot (6), or more simply by comparing the APS.
This latter method is more sensitive to small changes in
ef®ciency, and is easily performed without the need to assay
dilution series from each sample. Reductions in ef®ciency
indicate the likely presence of mismatches between template
DNA and primer or probe oligos without the need for
sequencing the fragment. Detecting such mismatches is
important for qPCR assays because their presence means
that the calculated amount of ampli®able DNA will be an
underestimation of the actual amount if measured against a
perfectly matched standard. In some cases it is possible to use
APS differences between sample reactions to detect the
presence of contaminating DNA within extracts (P.Wandeler
and S.Smith, manuscript in preparation). Contaminant DNA
competes with the target template during the PCR and, if there
are sequence differences at the probe or primer binding sites,
produces different APS characteristics when compared with
reactions containing only pure template. The magnitude of this
difference relates to the proportion of contaminant DNA in
the reaction, the extent of oligo binding site mismatches and
the amplicon length employed for the assay.
The assays used in this study can be applied to other
projects where accurate quanti®cation of ampli®able DNA is
required. The deep phylogenetic signal for this gene, which is
evident from the sequence alignment and Figure 2, suggests
that within species, polymorphism is likely to be very low.
This should facilitate the use of assays designed from this gene
for relative quanti®cation of samples. The sequence data
presented here can be used to design species-speci®c assays
for improved ef®ciency and also for the exclusion of
contaminating DNA such as human or prey species that
might otherwise confound the results. Caution must be taken
Figure 5. Plot of the APS values against (A) total number of mismatches
for the c-myc81 assay and (B) probe binding site mismatches for the
c-myc81 assay. Trendline and correlation coef®cient (R2) are shown for
each plot.
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with this approach, however, to ensure that DNA from other
species is indeed excluded by the assay. This can be
accomplished by designing probes with greater than two
mismatches to the contaminant template and also by increas-
ing the stringency of the assay conditions such that perfectly
matched template is exclusively ampli®ed. In addition to the
species tested here, the sequencing primers lie in conserved
regions of exon 3 of the c-myc proto-oncogene and are
suitable to use for assay design across a broad range of
mammalian species.
AD is a signi®cant problem for genotyping studies
employing small amounts of DNA, and qPCR has been
suggested as a means for improving genotyping ef®ciency and
accuracy (8). Data from this study support this conclusion, but
the application of an assay that measured quantity of DNA
template for a fragment more similar in size to those used in
typical microsatellite genotyping studies (the c-myc190 assay)
did not improve the predictive ability of qPCR to determine
numbers of repetitions required to obtain 99% con®dence of
genotypes. However, as a simple test of samples that should
perform with >95% ampli®cation success and <5% AD, the
c-myc190 PCR product can be used, with simple agarose gel
electrophoresis, to provide a sample quality cut-off when
qPCR instruments are not available (data not shown). This can
Figure 6. Plots of percentage positive PCR and percentage AD against DNA quantity (copy number) as measured by the (A) c-myc81 assay and (B) the
c-myc190 assay.
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be achieved after preliminary testing to associate AD rates and
target locus PCR success in the species and sample types of
interest.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Methods Online.
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